Diagnosis and management of mineral metabolism in CKD

Journal of General Internal Medicine

Volumn 25, Issue 7, 2010, Pages 710-716

  Bhan, Ishir ^a   Dubey, Anil ^a   Wolf, Myles ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

bisphosphonate; chronic kidney disease; osteoporosis

Indexed keywords

25 HYDROXYVITAMIN D; BISPHOSPHONIC ACID DERIVATIVE; PARATHYROID HORMONE; VITAMIN D;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST; DIALYSIS; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC BONE DISEASE; MINERAL METABOLISM; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; SECONDARY HYPERPARATHYROIDISM; VITAMIN D DEFICIENCY;

ADULT; AGED; AGED, 80 AND OVER; BONE DISEASES, METABOLIC; COHORT STUDIES; DISEASE MANAGEMENT; ELECTRONIC HEALTH RECORDS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 77954383121     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-010-1316-y     Document Type: Article

References (43)

1. J Coresh E Selvin LA Stevens, et al. 2007 Prevalence of chronic kidney disease in the United States JAMA. 298 17 2038 47 10.1001/jama.298.17.2038 1:CAS:528:DC%2BD2sXht1yjsLnM 17986697 (Pubitemid 350074801)
2. BC Astor P Muntner A Levin JA Eustace J Coresh 2002 Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994) Arch Intern Med 162 12 1401 8 10.1001/archinte.162.12.1401 12076240
3. AS Go GM Chertow D Fan CE McCulloch CY Hsu 2004 Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 1296 305 10.1056/NEJMoa041031 1:CAS:528:DC%2BD2cXnvFSgtr8%3D 15385656 (Pubitemid 39268908)
4. WG Goodman J Goldin BD Kuizon, et al. 2000 Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis N Engl J Med 342 20 1478 83 10.1056/NEJM200005183422003 1:STN:280: DC%2BD3c3ls1OjtA%3D%3D 10816185 (Pubitemid 30318271)
5. CY Lin LY Lin HK Kuo JW Lin 2009 Chronic kidney disease, atherosclerosis, and cognitive and physical function in the geriatric group of the National Health and Nutrition Survey 1999-2002 Atherosclerosis 202 1 312 9 10.1016/j.atherosclerosis.2008.04.020 1:CAS:528:DC%2BD1cXhsFajsb3M 18533156
6. DS Keith GA Nichols CM Gullion JB Brown DH Smith 2004 Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization Arch Intern Med 164 6 659 63 10.1001/archinte.164.6. 659 15037495 (Pubitemid 38392981)
7. K Martin E Gonzalez 2007 Metabolic Bone Disease in Chronic Kidney Disease J Am Soc Nephrol 18 3 875 85 10.1681/ASN.2006070771 1:CAS:528: DC%2BD2sXjs1GrsL0%3D 17251386 (Pubitemid 46434504)
8. GA Block PS Klassen JM Lazarus N Ofsthun EG Lowrie GM Chertow 2004 Mineral metabolism, mortality, and morbidity in maintenance hemodialysis J Am Soc Nephrol. 15 8 2208 18 10.1097/01.ASN.0000133041.27682.A2 1:CAS:528:DC%2BD2cXlvVKmu7w%3D 15284307 (Pubitemid 39031360)
9. OM Gutierrez M Mannstadt T Isakova, et al. 2008 Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis N Engl J Med 359 6 584 92 10.1056/NEJMoa0706130 1:CAS:528:DC%2BD1cXpt12qtro%3D 18687639
10. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(4 Suppl 3):S1-201, Oct.
11. GA Block KJ Martin AL de Francisco, et al. 2004 Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis N Engl J Med 350 15 1516 25 10.1056/NEJMoa031633 1:CAS:528:DC%2BD2cXjtVeqtLY%3D 15071126 (Pubitemid 38477776)
12. T Isakova OM Gutierrez Y Chang, et al. 2009 Phosphorus binders and survival on hemodialysis J Am Soc Nephrol 20 2 388 96 10.1681/ASN.2008060609 1:CAS:528:DC%2BD1MXjtFCrtLk%3D 19092121
13. M Teng M Wolf MN Ofsthun, et al. 2005 Activated injectable vitamin D and hemodialysis survival: a historical cohort study J Am Soc Nephrol. 16 4 1115 25 10.1681/ASN.2004070573 1:CAS:528:DC%2BD2MXjsVWqt70%3D 15728786 (Pubitemid 41710323)
14. MF Holick 2007 Vitamin D deficiency N Engl J Med. 357 3 266 81 10.1056/NEJMra070553 1:CAS:528:DC%2BD2sXotVejsbc%3D 17634462 (Pubitemid 47080391)
15. KJ Martin K Olgaard JW Coburn, et al. 2004 Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy Am J Kidney Dis 43 3 558 65 10.1053/j.ajkd.2003.12.003 14981615 (Pubitemid 38298216)
16. A Barone A Giusti G Pioli, et al. 2007 Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial J Am Geriatr Soc. 55 5 752 7 10.1111/j.1532-5415.2007.01161.x 17493196 (Pubitemid 46668979)
17. SR Mastaglia GG Pellegrini PM Mandalunis MM Gonzales Chaves SM Friedman SN Zeni 2006 Vitamin D insufficiency reduces the protective effect of bisphosphonate on ovariectomy-induced bone loss in rats Bone 39 4 837 44 10.1016/j.bone.2006.04.015 1:CAS:528:DC%2BD28XpsVOhtbc%3D 16765665 (Pubitemid 44322071)
18. S Boonen D Vanderschueren K Venken K Milisen M Delforge P Haentjens 2008 Recent developments in the management of postmenopausal osteoporosis with bisphosphonates: enhanced efficacy by enhanced compliance J Intern Med. 264 4 315 32 10.1111/j.1365-2796.2008.02010.x 1:CAS:528:DC%2BD1cXht1Omt7%2FK 18823505
19. Nickolas TL, Leonard MB, Shane E. Chronic kidney disease and bone fracture: a growing concern. Kidney Int. 2008;11, Jun.
20. DW Johnson HD McIntyre A Brown J Freeman RJ Rigby 1996 The role of DEXA bone densitometry in evaluating renal osteodystrophy in continuous ambulatory peritoneal dialysis patients Perit DIal Int. 16 1 34 40 1:STN:280: DyaK283gsVKnsw%3D%3D 8616170
21. JP Lea WM McClellan C Melcher E Gladstone T Hostetter 2006 CKD risk factors reported by primary care physicians: do guidelines make a difference? Am J Kidney Dis 47 1 72 7 10.1053/j.ajkd.2005.09.027 16377387 (Pubitemid 41828268)
22. LA Stevens G Fares J Fleming, et al. 2005 Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease J Am Soc Nephrol 16 8 2439 48 10.1681/ASN.2005020192 15930090 (Pubitemid 41725062)
23. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(2 Suppl 1):S1-266, Feb 1.
24. D DeFaria Yeh MW Freeman JB Meigs RW Grant 2007 Risk factors for coronary artery disease in patients with elevated high-density lipoprotein cholesterol Am J Cardiol 99 1 4 10.1016/j.amjcard.2006.07.053 1:CAS:528: DC%2BD2sXhsFGrtA%3D%3D 17196452 (Pubitemid 44969332)
25. RW Grant JB Meigs 2007 Prevalence and treatment of low HDL cholesterol among primary care patients with type 2 diabetes: an unmet challenge for cardiovascular risk reduction Diabetes Care 30 479 84 10.2337/dc06-1961 1:CAS:528:DC%2BD2sXjs1GrtL0%3D 17327308 (Pubitemid 46354321)
26. AP Weiss DC Henderson JB Weilburg, et al. 2006 Treatment of cardiac risk factors among patients with schizophrenia and diabetes Psychiatric services (Washington, DC) 57 1145 52
27. DJ Wexler RW Grant JB Meigs DM Nathan E Cagliero 2005 Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes Diabetes Care 28 514 20 10.2337/diacare.28.3.514 15735180 (Pubitemid 40315306)
28. RF Charles NR Powe BG Jaar MU Troll RS Parekh LE Boulware 2009 Clinical testing patterns and cost implications of variation in the evaluation of CKD among US physicians Am J Kidney Dis 54 2 227 37 10.1053/j.ajkd.2008.12.044 19371991
29. M Wolf A Shah O Gutierrez, et al. 2007 Vitamin D levels and early mortality among incident hemodialysis patients Kidney Int. 72 8 1004 13 10.1038/sj.ki.5002451 1:CAS:528:DC%2BD2sXhtFagtr%2FM 17687259 (Pubitemid 47530570)
30. O Gutierrez T Isakova E Rhee, et al. 2005 Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease J Am Soc Nephrol 16 7 2205 15 10.1681/ASN.2005010052 1:CAS:528:DC%2BD2MXms1egsLs%3D 15917335 (Pubitemid 41716454)
31. NA Hamdy JA Kanis MN Beneton, et al. 1995 Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure BMJ. 310 6976 358 63 1:STN:280:DyaK2M7ntVGisw%3D%3D 7677827
32. PD Miller C Roux S Boonen IP Barton LE Dunlap DE Burgio 2005 Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials J Bone Miner Res 20 12 2105 15 10.1359/JBMR.050817 1:CAS:528: DC%2BD2MXhtlWntrbN 16294264 (Pubitemid 41698774)
33. Lenart B, Neviaser A, Lyman S, et al. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int. 2008, Dec 9.
34. BA Lenart DG Lorich JM Lane 2008 Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate N Engl J Med 358 12 1304 6 10.1056/NEJMc0707493 1:CAS:528:DC%2BD1cXjvVarsb8%3D 18354114 (Pubitemid 351439247)
35. CV Odvina JE Zerwekh DS Rao N Maalouf FA Gottschalk CY Pak 2005 Severely suppressed bone turnover: a potential complication of alendronate therapy J Clin Endocrinol Metab. 90 3 1294 301 10.1210/jc.2004-0952 1:CAS:528: DC%2BD2MXisVOhsr0%3D 15598694 (Pubitemid 40463979)
36. Visekruna M, Wilson D, McKiernan FE. Severely suppressed bone turnover and atypical skeletal fragility. J Clin Endocrinol Metab. Aug 1 2008;93(8):2948-2952.
37. CP Kovesdy S Ahmadzadeh JE Anderson K Kalantar-Zadeh 2008 Association of activated vitamin D treatment and mortality in chronic kidney disease Arch Intern Med 168 4 397 403 10.1001/archinternmed.2007.110 1:CAS:528: DC%2BD1cXjtlemsrw%3D 18299495 (Pubitemid 351350586)
38. Shoben AB, Rudser KD, De Boer IH, Young B, Kestenbaum B. Association of Oral Calcitriol with Improved Survival in Nondialyzed CKD. J Am Soc Nephrol. May 2008:7.
39. RJ Glassock C Winearls 2008 An epidemic of chronic kidney disease: fact or fiction? Nephrol Dial Transplant 23 4 1117 21 10.1093/ndt/gfn086 18359870 (Pubitemid 351767536)
40. Osteoporosis/fracture prevention clinical practice guidelines. http://www.guideline.gov/summary/summary.aspx?doc-id=13967&nbr=007057. Accessed January 22, 2010.
41. Clinician's Guide to Prevention and Treatment of Osteoporsosis. Washington, DC: National Osteoporosis Foundation; 2008.
42. V Agrawal AK Ghosh MA Barnes PA McCullough 2008 Awareness and knowledge of clinical practice guidelines for CKD among internal medicine residents: a national online survey Am J Kidney Dis 52 6 1061 9 10.1053/j.ajkd.2008.06.022 18976845
43. P Drawz M Rahman 2009 In the clinic. Chronic kidney disease Ann Intern Med 150 3 ITC2-1 15 quiz ITC12-16